J&J Backs Down to EU Over $21 Billion Synthes Deal

Johnson & Johnson has offered unnamed concessions meant to ease the European Commission’s antitrust concerns over the company’s proposed $21.3 billion acquisition of leading orthopedic device maker Synthes.
Law360